Proton therapy in the management of hepatocellular carcinoma Review
| Authors: | Kobeissi, J. M.; Hilal, L.; Simone, C. B. 2nd; Lin, H.; Crane, C. H.; Hajj, C. |
| Review Title: | Proton therapy in the management of hepatocellular carcinoma |
| Abstract: | Simple Summary: Radiation therapy is among the locoregional therapy modalities used to treat unresectable or medically inoperable hepatocellular carcinoma (HCC). Proton radiation therapy plays a major role in the treatment of HCC, especially when liver toxicity is a concern. The aim of this review is to provide a concise and comprehensive summary on the use of proton therapy in the management of HCC. Proton radiation therapy plays a central role in the treatment of hepatocellular carcinoma (HCC). Because of the near-zero exit dose and improved sparing of normal liver parenchyma, protons are being used even in challenging scenarios, including larger or multifocal liver tumors, and those associated with vascular tumor thrombus. There is a mounting level of evidence that suggests that protons are superior to photons in terms of survival and toxicity outcomes, specifically the progression to liver failure. A randomized controlled trial comparing protons to photons is currently underway to verify this hypothesis. |
| Journal Title: | Cancers |
| Volume: | 14 |
| Issue: | 12 |
| ISSN: | 2072-6694 |
| Publisher: | MDPI |
| Date Published: | 2022-06-02 |
| Start Page: | 2900 |
| Language: | English |
| DOI: | 10.3390/cancers14122900 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| PMCID: | PMC9220794 |
| PUBMED: | 35740567 |
| DOI/URL: | |
| Notes: | Accession Number: 157680642 -- Entry Date: In Process -- Revision Date: 20220630 -- Publication Type: Article -- Journal Subset: Biomedical; Continental Europe; Europe -- NLM UID: 101526829. -- Source: Cinahl |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work